{
    "clinical_study": {
        "@rank": "147859", 
        "arm_group": [
            {
                "arm_group_label": "optive\u00ae eye drop", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "fresh tears \u00ae eye drop", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this project is to determine the effectiveness of an eyewash osmoprotective\n      lubricant comparing to castor oil containing and non-osmoprotective lubricants in different\n      types of DTS and post refractive surgery patients."
        }, 
        "brief_title": "Osmoprotective and Castor Oil Containing Lubricants in Dysfunctional Tear Syndrome and Post Refractive Surgery Patients", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dry Eye", 
            "Ametropia"
        ], 
        "condition_browse": {
            "mesh_term": "Refractive Errors"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Adult patients willing and able to comply with the protocol who are not planning\n             changes in diet, topical or systemic drugs during the course of study.\n\n          2. DTS all the patients will be diagnosed for mild to moderate evaporative dry eye as\n             defined by following criteria that will be given by Outcome measurements:\n\n             2.1. Break up time. 2.2. Lissamine green staining. 2.3. OSDI and Patient\n             Symptomatology Questionnaire.\n\n          3. The patients, whose are going to be submitted for refractive surgery.\n\n        Exclusion Criteria:\n\n          1. Any patient with punctual occlusion or punctual plugs.\n\n          2. Patients with active ocular infection or inflammatory disease, history of herpetic\n             keratitis, history of retinal detachment, concurrent contact lens use during trial\n             period,\n\n          3. Patients with glaucoma, anterior membrane dystrophy, active trichiasis or any eyelid\n             globe malposition abnormality.\n\n          4. Patients with Epiphora.\n\n          5. Patients must not have participated in any investigational therapeutic drug or device\n             trial within the 30 days prior to their start date for this trial.\n\n          6. Any patient suffering from organic brain syndromes or major psychiatric disorder that\n             would interfere with compliance or subjective reporting will be discouraged from\n             participating in this trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01741987", 
            "org_study_id": "1346/08"
        }, 
        "intervention": [
            {
                "arm_group_label": "fresh tears \u00ae eye drop", 
                "description": "instilation of 1 drop each eye 4 times per day", 
                "intervention_name": "Optive \u00ae", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "optive\u00ae eye drop", 
                "description": "instilation of eye drop 4 times a day (qid)", 
                "intervention_name": "Fresh Tears \u00ae", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Castor Oil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 3, 2013", 
        "link": [
            {
                "description": "eye diseases", 
                "url": "http://www.nlm.nih.gov/medlineplus/eyediseases.html"
            }, 
            {
                "description": "FDA Resources on Drugs and Devices", 
                "url": "http://clinicaltrials.gov/ct2/info/fdalinks"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Sao Paulo", 
                    "country": "Brazil", 
                    "state": "SP"
                }, 
                "name": "Department of Ophthalmology, UNIFESP&EPM"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Effectiveness of Osmoprotective and Castor Oil Containing Lubricants in Dysfunctional Tear Syndrome (DTS) and Post Refractive Surgery Patients", 
        "other_outcome": [
            {
                "measure": "Our purpose is to determine the differential effects of Optive\u00ae vs. FreshTears \u00ae on post refractive surgery patients.", 
                "safety_issue": "No", 
                "time_frame": "3 monthas"
            }, 
            {
                "measure": "change from baseline in Ocular Surface Disease Index (OSDI)", 
                "safety_issue": "No", 
                "time_frame": "3 moths"
            }, 
            {
                "measure": "change from baseline in tear break up time (BUT)", 
                "safety_issue": "No", 
                "time_frame": "3 mothas"
            }, 
            {
                "measure": "change from baseline in lissamine green staining", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "change form baseline in impression cytology", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "change from baseline in tear osmolarity", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "overall_official": {
            "affiliation": "Department of Ophtahlmology, UNIFESP& EPM, Sao Paulo, SP, Brazil", 
            "last_name": "Rossen M Hazarbassanov, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "patients satisfaction with osmoprotective lubricant on different types DTS.", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01741987"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Rossen Mihaylov Hazarbassanov, MD, PhD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Our purpose is to determine the differential effects of Optive\u00ae castor oil Endura \u00ae on different types DTS.", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Physician satisfaction with Optive\u00ae", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of S\u00e3o Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}